Skip to main content
NIH funding notice RFA-AI-17-036

Repurposing Target-Based Pharmaceutical Libraries for Discovery of Therapeutics against Eukaryotic Pathogens (R21/R33)

Closed on January 12, 2018.

Posted
September 12, 2017
Close date
January 12, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

10 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,377,555 in first-year total cost, median $236,339.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 TS-M (S1)]10

Most frequent institutions

  1. BOSTON CHILDREN'S HOSPITAL1
  2. BROAD INSTITUTE, INC.1
  3. DARTMOUTH COLLEGE1
  4. NORTHEASTERN UNIVERSITY1
  5. UNIVERSITY OF CALIFORNIA, SAN DIEGO1
Competing awards under RFA-AI-17-036 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019Screening a Target-Based Repurposing Library for Activity against Fungal Pathogens and Subsequent Preclinical Development of Leading Candidates1R21AI140823-01LOPEZ-RIBOT, JOSE L.WORMLEY, FLOYD L.UNIVERSITY OF TEXAS SAN ANTONIO, TX$313,188ZAI1
2019A High-Throughput Chemical Screen to Identify Inhibitors of the Fungal Azole Transporter Cdr1p1R21AI141089-01BERNARDO, STELLA MARIEHOUGHTEN, RICHARD ALLENLEE, SAMUEL AUSTINSKLAR, LARRY A.UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR, NM$273,077ZAI1
2019Compounds that block a novel Candida albicans target1R21AI141189-01KOEHLER, JULIA RBOSTON CHILDREN'S HOSPITAL, MA$260,110ZAI1
2019Overcoming Emerging Aspergillus fumigatus Azole Resistance Via Protease Inhibition1R21AI140878-01CRAMER, ROBERT ANDREWDARTMOUTH COLLEGE, NH$245,500ZAI1
2019Discovering novel antifungal agents via multi-species profiling of a structurally and stereochemically diverse, well-validated compound library1R21AI141080-01NAG, PARTHA PRATIMBROAD INSTITUTE, INC., MA$239,354ZAI1
2019Discovery of therapeutics against Cryptococcosis by Repurposing Pharmaceutical Libraries1R21AI141178-01LI, HONGMINWADSWORTH CENTER, NY$233,323ZAI1
2019Development of Dual Efficacy Therapeutic Against Cryptosporidiosis and Giardiasis1R21AI140881-01OJO, KAYODE KUNIVERSITY OF WASHINGTON, WA$220,365ZAI1
2019Repurposing the EMD-Serono "mini-library" for Cryptosporidium drug development1R21AI141184-01GRIGGS, DAVIDHUSTON, CHRISTOPHER DMEYERS, MARVIN JUNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VT$206,487ZAI1
2019Lead optimization of hits identified from virtual and experimental screens of multiple industrial libraries DNDi1R21AI141227-01POLLASTRI, MICHAEL PNORTHEASTERN UNIVERSITY, MA$197,029ZAI1
2019Brain Penetrant Microtubule-Stabilizers to Treat CNS-invasive Parasitic Diseases1R21AI141210-01BALLATORE, CARLOCAFFREY, CONORDEBNATH, ANJANUNIVERSITY OF CALIFORNIA, SAN DIEGO, CA$189,122ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AI-17-036: Repurposing Target-Based Pharmaceutical Libraries for Discovery of Therapeutics against Eukaryotic Pathogens (R21/R33) | ScienceDex | ConductScience